Edgar Ramiterre
Impact in
- Immunology top 5%
- Biosimilars and Bioanalytical Methods
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
-
- Biosimilars and Bioanalytical Methods 6
- Immunodeficiency and Autoimmune Disorders 2
-
- Rheumatoid Arthritis Research and Therapies 3
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Dae‐Hyun YooPedro C. MirandaHoUng KimWon ParkNenad ProdanovićMichael TeeSergio Gutiérrez‐UreñaOmid Zamani
- Journals
- Annals of the Rheumatic Diseases (9 papers)Abstracts (1 paper)
- Partner nations
- United StatesSouth KoreaMexico
In The Last Decade
Edgar Ramiterre
10 papers receiving 773 citations
Hit Papers
Peers
Comparison fields: 5 of 39
- Immunology 694
- Rheumatology 291
- Pediatrics, Perinatology and Child Health 227
- Economics and Econometrics 222
- Radiology, Nuclear Medicine and Imaging 136
Countries citing papers authored by Edgar Ramiterre
This map shows the geographic impact of Edgar Ramiterre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Ramiterre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Ramiterre more than expected).
Fields of papers citing papers by Edgar Ramiterre
This network shows the impact of papers produced by Edgar Ramiterre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Ramiterre. The network helps show where Edgar Ramiterre may publish in the future.
Co-authors
The 25 scholars most cited alongside Edgar Ramiterre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 74 | |
| 2 | 2019 | 2 | |
| 3 | 2016 | 203 | |
| 4 | 2014 | 6 | |
| 5 | 2014 | 1 | |
| 6 | A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Hit paper breakdown → | 2013 | 487 |
| 7 | 2013 | 4 | |
| 8 | 2013 | 2 | |
| 9 | 2013 | 2 | |
| 10 | 2012 | 9 |
About Edgar Ramiterre
Edgar Ramiterre is a scholar working on Immunology, Rheumatology, Radiology, Nuclear Medicine and Imaging, Genetics and Pediatrics, Perinatology and Child Health, having authored 10 papers that have together received 790 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Pharmaceutical studies and practices (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Systemic Lupus Erythematosus Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Immunology (694 citations), Rheumatology (291 citations), Pediatrics, Perinatology and Child Health (227 citations), Economics and Econometrics (222 citations) and Radiology, Nuclear Medicine and Imaging (136 citations). Edgar Ramiterre has collaborated with scholars based in United States, South Korea and Mexico. Frequent co-authors include Dae‐Hyun Yoo, Pedro C. Miranda, HoUng Kim, Won Park, Nenad Prodanović, Michael Tee, Sergio Gutiérrez‐Ureña, Omid Zamani, Ulf Müller‐Ladner and Volodymyr Kovalenko. Their work appears in journals such as Annals of the Rheumatic Diseases and Abstracts.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.